Last reviewed · How we verify

NCT05081037: I-HIPS

Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)

Recruiting now NA Last updated 17 April 2025
What this trial tests

NA trial testing Wearable Care Group in Gestational Diabetes in 300 participants. Currently enrolling.

Timeline
6 September 2021
Primary endpoint
26 May 2026
26 May 2026

Quick facts

Lead sponsorKK Women's and Children's Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment300
Start date6 September 2021
Primary completion26 May 2026
Estimated completion26 May 2026
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

KK Women's and Children's Hospital

Who can join

Adults 21 to 45, female only, with Gestational Diabetes or Glucose Metabolism Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to test the following hypotheses in a randomized controlled trial of post-partum women with a history of gestational diabetes mellitus (GDM) that will be followed up for up to 4 years: 1. Post-partum pregnancy is ideal for behavioural modification and adopting a healthy lifestyle. Using the continous glucose monitoring (CGM) sensor and an exercise tracker will promote self-motivation and awareness by positive reinforcement and behavioural changes to improve diet, control body weight and increase physical activity in this group of post-partum women who are at high risk for developing Type II Diabetes. 2. The use of the continous glycose monitoring (CGM) sensor and exercise tracker will motivate women to modify their dietary food intake and physical activity over time, reducing their cardiovascular risk factors for developing metabolic syndrome by lowering their baseline blood pressure, BMI, reducing their waist circumference and body fat mass, glycaemic levels and fasting lipids within the targeted healthy range. 3. There will be an increase in the quality adjusted life years (QALYs) gained based on improvements in HbA1C and other proximal outcomes at the end of the trial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Lifestyle intervention to prevent postpartum type 2 diabetes in Asian women with recent gestational diabetes and normal post-pregnancy glucose tolerance: study protocol for a randomized controlled trial with a targeted postpartum lifestyle programme.
    Quah PL, Song H, Han WM, Lim EJK, et al · · 2026 · PMID 41673699 · DOI 10.1186/s13063-026-09516-7

Verify or expand the search:

Other recruiting trials for Gestational Diabetes

Currently open trials in the same condition.

Other KK Women's and Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05081037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing